BAC
Bank of America Corporation
BAC has the edge over SSBI overall, supported by stronger modeled upside and lower modeled downside.
SSBI
Summit State Bank
SSBI trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
SSBI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
SSBI's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like SSBI.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over SSBI in the historical PE scenario, which offers more potential upside but is not a forecast.
SSBI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6x | $2.06 | -83% |
| Fair | 7.8x | $2.64 | -78% |
| Expensive | 11x | $3.65 | -70% |
| Current | 35x | $12.01 | — |
Historical ranges are pointers, not guarantees.
SSBI's PE is in its expensive range at 35x.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
SSBI Forward outlook
There aren't enough analyst estimates for SSBI to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over SSBI on earnings, with more consistent year-over-year improvement.
SSBI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.34 | +$0.58 |
| Q1 2026 | $0.89 | +$1.35 |
| Q4 2025 | $1.01 | +$1.63 |
| Q3 2025 | -$0.21 | -129% |
| Q2 2025 | -$0.24 | -127% |
| Q1 2025 | -$0.46 | -138% |
| Q4 2024 | -$0.62 | -138% |
| Q3 2024 | $0.72 | -64% |
SSBI has returned to profit: it earned $0.34 per share over the past year, after losing money the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over SSBI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over SSBI on profitability, with a higher operating margin.
SSBI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $15M | -3.2% |
| Q1 2026 | $15.1M | -0.9% |
| Q4 2025 | $13M | -15% |
| Q3 2025 | $15.1M | -5.6% |
| Q2 2025 | $15.5M | +2.1% |
| Q1 2025 | $15.2M | -1.5% |
| Q4 2024 | $15.4M | +2.9% |
| Q3 2024 | $16M | -2.3% |
SSBI's revenue is shrinking: $15M last quarter, down 3.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -13% | -34 points |
| Q1 2026 | 15% | -5.3 points |
| Q4 2025 | 10% | +66 points |
| Q3 2025 | 8.4% | +3.2 points |
| Q2 2025 | 21% | +13 points |
| Q1 2025 | 20% | +7.2 points |
| Q4 2024 | -55% | -74 points |
| Q3 2024 | 5.2% | -10 points |
SSBI's operating margin was −13% last quarter, down 34 points from the same quarter a year ago, near the bottom of its range since 2019.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
SSBI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $4.2M | +$4.2M |
| Q1 2026 | $3.8M | +$7M |
| Q4 2025 | $2.6M | +58% |
| Q3 2025 | $7.2M | +215% |
| Q2 2025 | -$66K | -106% |
| Q1 2025 | -$3.2M | -596% |
| Q4 2024 | $1.7M | +$2.7M |
| Q3 2024 | $2.3M | +$4.7M |
SSBI has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over SSBI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
SSBI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +13.3K shares |
| 1 year | +0.2% | +13.7K shares |
| 3 years | +0.7% | +47.5K shares |
| 5 years | +1% | +65.5K shares |
| Available history | +1% | +66.1K shares |
SSBI has 7M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $12,000 |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
SSBI hasn't bought back shares in the past year.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
SSBI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -33.1x | Net Cash |
| Q1 2026 | -12.9x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2024 | -10.3x | Net Cash |
| Q2 2024 | -3.4x | Net Cash |
| Q1 2024 | -0.3x | Net Cash |
| Q4 2023 | -3.3x | Net Cash |
| Q3 2023 | -4.2x | Net Cash |
SSBI has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
SSBI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.2 | Neutral |
| Stochastic | 13.2 | Oversold |
SSBI's weekly RSI is 43 (neutral) and its Stochastic is 13 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over SSBI on valuation relative to its sector.
SSBI PE vs Financial Services Sector
| Metric | SSBI | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 13x | 171% above |
| PE % | 99 | 63 | 36 pts above |
SSBI is trading at 35x earnings, a 171% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
SSBI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.0 | 0.1% below |
| 20 week MA | $12.6 | 4.4% below |
| 50 week MA | $12.9 | 7% below |
| 100 week MA | $11.4 | 5.4% above |
| 200 week MA | $11.8 | 2.1% above |
SSBI has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
SSBI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.7 | $11.4 | -2.3% |
| 2021 | $11.4 | $15.4 | +35% |
| 2022 | $15.4 | $15.3 | -0.3% |
| 2023 | $15.3 | $12.3 | -20% |
| 2024 | $12.3 | $7.59 | -38% |
| 2025 | $7.59 | $11.8 | +55% |
| 2026 YTD | $11.8 | $12.0 | +2.2% |
SSBI has the edge over BAC on returns for 2026, with the stronger performance.